Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Danes review UK/French proposal on CNS (central nervous system) devices:

This article was originally published in Clinica

Executive Summary

The Danish medical device industry association, Medicoindustrien, is seeking the views of its members on one of the controversial proposals put forward by the French and UK authorities which are intended to tighten the requirements of the Medical Devices Directive (MDD). It is asking for comments on the UK and French proposal that invasive devices intended for use in the central nervous system for less than 60 minutes be placed in class III, the highest risk class, in future. At present, Rule 6 of the MDD generally places invasive devices for transient use in class IIa.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel